Bios Equity COF, LP Insider Profile

4 Followers
Bios Equity COF, LP, Director, Ten Percent Owner at Actuate Therapeutics, Inc., holds 231.38K shares in Actuate Therapeutics, Inc. (Ticker: ACTU). Most recently, Bios Equity COF, LP ― shares of Actuate Therapeutics, Inc. on ― for an estimated value of ―.
tipranks
Bios Equity COF, LP

Bios Equity COF, LP
Actuate Therapeutics, Inc. (ACTU)
Director, Ten Percent Owner

Not Ranked
Bios Equity COF, LP has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Bios Equity COF, LP's holdings

Insider Roles

Actuate Therapeutics, Inc.
(ACTU)
Director, Ten Percent Owner
Roles that Bios Equity COF, LP holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Bios Equity COF, LP

Bios Equity COF, LP's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Actuate Therapeutics, Inc.
Director, Ten Percent Owner
$2.01M
Bios Equity COF, LP has not reported any informative transactions for ACTU, therefore, performance cannot be measured.
List of latest transactions for each holding click on a transaction to see Bios Equity COF, LP's performance on stock

Bios Equity COF, LP insider profile FAQ

What is the percentage of profitable transactions made by Bios Equity COF, LP?
The percentage of profitable transactions made by Bios Equity COF, LP is ―.
    What is the average return per transaction made by Bios Equity COF, LP?
    The average return per transaction made by Bios Equity COF, LP is ―.
      What stocks does Bios Equity COF, LP hold?
      Bios Equity COF, LP holds: ACTU stocks.
        What was Bios Equity COF, LP’s latest transaction?
        Bios Equity COF, LP latest transaction was an Uninformative Buy of ―.
          What was Bios Equity COF, LP's most profitable transaction?
          Bios Equity COF, LP’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Bios Equity COF, LP's role in Actuate Therapeutics, Inc.?
            Bios Equity COF, LP's role in Actuate Therapeutics, Inc. is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.